Panel Sessions
The Haas Healthcare Conference brings together top business leaders, innovators, and entrepreneurs to discuss the most pressing healthcare issues. This year, we look forward to discussing the new ways of breaking down current silos and barriers through exciting collaborations and crucial partnerships.
​
10:00am Morning Panels
Sarah Scholle
VP of Research & Analysis
National Committee for Quality Assurance
Moderator
The Business Case for Cultural Competence:
Health care companies are increasingly focused on frameworks to address health equity and social determinants. Among these is cultural competence: an approach that honors the cultural preferences and socioeconomic influences that shape patient choices, behaviors, and outcomes.
Join us for a discussion about how stakeholders can collaborate to create the financial case for achieving health equity through culturally competent care.
Reaching Across Populations to Provide Culturally Competent Care
Winston Wong
Medical Director
Kaiser Permanente
Susan Philip
Board member
San Francisco Community Health Center
Julie Tinker
Senior Designer
Hopelab
Igor Belokrinitksy
Vice President and Partner
Strategy&, PwC
Moderator
Healthcare has transformed into a consumer experience where companies need to overcome the challenges of providing quality service and addressing patient barriers.
Join us to hear the best practices of building sustainable business models with a patient-friendly, highest-needs population focus.
​
​
Bringing Ideal Consumer Experiences to Healthcare
Dan Trigub
Head of Business Development
Uber Health
Brad Kittredge
CEO/Founder
Brightside
Lauren Devos
Head of Strategic Initiatives, Product Manager
Solv Health
Eyal Gurion
Senior Vice President
Integrated Healthcare Association
1:00pm Early Afternoon Panels
Martin Smith
Vice President
Claritas
Panelist / Moderator
Exogenous factors such as genomics, behavior, and social and environmental influences play a critical role in delivering outcomes and value for patients and health systems. Meanwhile, technology is finally allowing the capture and analysis of such real-world data.
Beyond previous safety and post-market use cases, learn about more integrated use of RWE across the end-to-end product cycle: to support regulatory decisions, advance disease understanding and clinical guidelines, and support outcome based reimbursement decisions.
Cracking Development Silos Between Clinical Trials and Real World Evidence
Dan Burnett
Founder
TheraNova
Marco Sorani
Associate Director, Product Development - Personalized Healthcare
Genentech
Sheila Baxter
Senior Director of Business Development
Conduent
Moderator
​
Andrea Bloom
Founder & CEO
ConnectWell
​
Abhinav Shashank
Co-Founder & CEO
Innovaccer
​
Matt Holman
Director
Camber Collective
​
Kelly Ling
Director of Enterprise Initiatives
Change Healthcare
Despite the trend toward value-based care and wraparound services that address patient needs holistically, the market for technology solutions incorporating the social determinants of health is nascent: as of June 2018, fewer than 4% of health systems and managed care organizations have invested in this technology. This panel will include perspectives on opportunities and challenges in this relatively new market.
Social Determinants of Health Technology for Population Health
3:00pm Late Afternoon Panels
Robin Flagg
Lecturer, Health Policy & Management
UC Berkeley School of Public Health
Moderator
​
Murray Ross
Vice President and Director
Institute for Health Policy, Kaiser Permanente
​
Gary Cohen
Vice President of Government Affairs
Blue Shield Of California
​
Sarah de Guia
Executive Director
California Pan-Ethnic Health Network
​
Jane García
CEO
La Clínica de La Raza
​
Naomi Newman
Director
Manatt, Phelps & Phillips, LLP
Medicaid is quickly becoming the key to expanding health coverage in America. Newly-elected democratic governors across the country are growing Medicaid, including Governor Gavin Newsom who has proposed expanding Medicaid to cover more undocumented immigrants. What innovations are driving Medicaid's popularity and sustainability? What does the expansion of Medicaid in states like California mean for the country's larger healthcare debate? Why has Medicaid succeeded where the ACA has failed?
Join us as we discuss the current surge and future of Medicaid in the United States.